Financial statements Pharma System
Balance sheet data of PHARMA SYSTEM
|
Year
|
2021
|
2022
|
|---|---|---|
| Total assets | 41 788,89 | 8 958 401,17 |
| A. Fixed assets | 27 777,78 | 7 024 798,72 |
| B. Current assets | 14 011,11 | 1 933 602,45 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 |
| Total liabilities | 41 788,89 | 8 958 401,17 |
| A. Equity | 7 316,69 | 7 270 902,32 |
| B. Liabilities and provisions for liabilities | 34 472,20 | 1 687 498,85 |
| I. Long-term liabilities | 0,00 | 75 000,00 |
| II. Short-term liabilities | 34 472,20 | 1 612 498,85 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.